Last Updated: 15th November 2022
Pfizer is a biopharmaceutical company that develops new medicines and vaccines to save and change the lives of people around the world suffering from all types of diseases.
You might know of them from their COVID-19 vaccine.
Employees: 79,000
Revenue: $81.3bn for FY2021
HQ Location: Manhattan, New York, USA
What they do:
They innovate, discover, develop and provide over 150 different medicines and vaccines to millions of people across the world
Their portfolio also includes many well-known consumer healthcare products
There are 6 divisions of Pfizer: Consumer Healthcare, Inflammation and Immunology, Internal Medicine, Oncology, Rare diseases, and Vaccines
Their vision and priorities:
Their vision is to find the best science in the world, in order to be the best innovator to bring medicines and therapies to the world faster.
Their priorities focus on six areas: product innovation, access to products at a fair price, product quality and safety, diversity, equity and inclusion, climate change, and business ethics.
“Breakthroughs that change patients’ lives”
Three things to know right now
A new commercial structure has been established in the global biopharmaceutical business
The structure focuses on 3 broad therapeutic areas: primary care, specialty care, and oncology. The new structure has been developed to maximize the commercial success of all the new product launches taking place over the next few years.
They continue the study in the fight against respiratory disease
They continue to develop game-changing vaccines for their mRNA flu vaccine as well as initiating a study that will combine the mRNA flu and Covid vaccine in one shot.
Completed 2 acquisitions
They completed the acquisitions of Biohaven Pharmaceuticals and Global Blood Therapeutics giving them market-leading franchises in both migraine and sickle-cell diseases.
What does each business unit do?
Consumer Healthcare
This business group focuses on over-the-counter drugs that include medicines that are sold to consumers directly without a prescription from a medical professional.
Inflammation and Immunology
This business group focuses on discovering the next generation of therapies for immune-mediated diseases. Those diseases where the immune cells act abnormally attacking the body or display abnormal behavior in the body.
Internal Medicine
This business group focuses on treatments and therapies in neuroscience and pain, cardiovascular and metabolic.
Oncology
This business group focuses on creating a pipeline of new cancer drugs, treatments and clinical trials that improve the outlook for cancer patients worldwide.
Rare Disease
This business group focuses on an adoptive and collaborative approach to the development of new medicines for patients with rare diseases.
Vaccines
This business group focuses on advancing vaccines for additional serious childhood, adolescent, and adult infections including meningococcal disease, influenza, Lyme disease and more in addition to it’s Covid-19 vaccine.
Their financial calendar
Q1: January-March - Earnings 3rd May
Q2: April-June - Earnings 28th July
Q3: July-September - Earnings 1st November
Q4: September-December - Earnings 4th January
Positives from the last earnings report:
Stellar financial performance of $22.6bn in Q3 2022
They have several pipeline programs on the go including an RSV vaccine for older adults, Prevnar20 for children, a combination drug treatment for men with prostate cancer, a meningococcal vaccine for adolescents and young adults, and exciting programs for Type 2 diabetics and obese patients
Challenges from the last earnings report:
They predict that the pandemic has peaked and therefore Covid -19 vaccine sales will start to decline into the next quarter. Pfizer is however not too concerned due to their recent acquisitions and therefore predicted future sales.
Next Earnings Report:
Around 4th January 2023
Something to add?
If you have new information that would help others, drop us a note through this form and we’ll verify prior to updating this page.
Thanks for helping,